{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/64993c07df717d00111a2314/64993c12257aec0011038140?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"EyePod - 74 - Bilateral Anti-VEGF Treatment","description":"<p>Welcome to EyePod Bayer!</p>\n<p>In the upcoming episodes we will focus on Viewpoints from the Vision Academy. The Vision Academy is a partnership between Bayer and ophthalmic specialists, established with the aim of addressing key clinical challenges in the field of retinal diseases.<br>\r\nToday we are presenting the viewpoint: Bilateral Anti-VEGF treatment and I have my colleague and medical advisor Haleh Davanian with me.</p>\n<p><a href='mailto:EyePod@Bayer.com'>EyePod@Bayer.com</a></p>\n<p>MA-M_AFL-DK-0175-1<br>\r\n</p>\n<p> </p>","author_name":"Bayer Oftalmologi"}